Biotech startups that raised Series C in Cambridge, Massachusetts
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Terrestrial Bio | Cambridge | Series C | $50.0M | 2026-03-26 |
| Cognito Therapeutics | Cambridge | Series C | $105.0M | 2026-03-05 |
| Ajax Therapeutics | Cambridge | Series C | $95.0M | 2024-05-13 |
| ConcertAI | Cambridge | Series C | $150.0M | 2022-03-29 |
4 rows of the CSV in 5 of its 18 columns.
- The 23 biotech startups in Cambridge, Massachusetts whose last round is Series C have raised $3.8B in total.
- 4 of them closed their most recent round in the last 12 months, $255.0M combined.
- The largest of those rounds is Cognito Therapeutics' $105.0M Series C, dated March 2026.
- The most recent is Sanyou Bio's $15.0M Series C on 9 November 2026.
- RA Capital Management is an investor in 2 of them, more than any other fund.
- Health care is the most common other sector, with 22 companies (96%).
- 9% were founded in 2020 or later; the median founding year is 2015.
- The most common team size is 11 to 50 employees (39% of companies with a recorded size).
- 1 is a unicorn, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
3 of 23| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Terrestrial Bio | Terrestrial Bio develops biomedical innovations aimed at improving access to vaccines. | Biotech | Series C | $50.0M | 2026-03-26 | $180.9M | RA Capital Management, National Institutes of Health, The Engine | 11 to 50 | 2012 |
| Cognito Therapeutics | Cognito Therapeutics develops neurotechnology therapies that stimulate brain activity to treat neurodegenerative diseases. | Biotech | Series C | $105.0M | 2026-03-05 | $321.8M | Morningside, FoundersX Ventures, IAG Capital Partners +1 | 11 to 50 | 2016 |
| ConcertAI Unicorn | ConcertAI sells AI-powered SaaS data tools for medical research in oncology. | Artificial intelligence | Series C | $150.0M | 2022-03-29 | $300.0M | Maverick Ventures, Sixth Street, Declaration Partners +2 | 1,001 to 5,000 | 2018 |
Table 1. Biotech startups that raised Series C in Cambridge, Massachusetts: the 3 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 23.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Cognito Therapeutics | Cognito Therapeutics develops neurotechnology therapies that stimulate brain activity to treat neurodegenerative diseases. | Biotech | Series C | $105.0M | 2026-03-05 | $321.8M | Morningside, FoundersX Ventures, IAG Capital Partners +1 | 11 to 50 | 2016 |
| 2 | Terrestrial Bio | Terrestrial Bio develops biomedical innovations aimed at improving access to vaccines. | Biotech | Series C | $50.0M | 2026-03-26 | $180.9M | RA Capital Management, National Institutes of Health, The Engine | 11 to 50 | 2012 |
Table 2. Biotech startups that raised Series C in Cambridge, Massachusetts: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | RA Capital Management | Startup incubator | Boston, United States | 2 | 9% | 1 | Terrestrial Bio |
| 2 | National Institutes of Health | Entrepreneurship program | Bethesda, United States | 1 | 4% | 1 | Terrestrial Bio |
| 3 | The Engine | Venture capital firm | Cambridge, United States | 1 | 4% | 1 | Terrestrial Bio |
| 4 | IAG Capital Partners | Venture capital firm | Charleston, United States | 1 | 4% | 1 | Cognito Therapeutics |
| 5 | Starbloom Capital | Family office | Houston, United States | 1 | 4% | 1 | Cognito Therapeutics |
| 6 | Morningside | Private equity firm | Newton, United States | 1 | 4% | 1 | Cognito Therapeutics |
| 7 | FoundersX Ventures | Venture capital firm | Menlo Park, United States | 1 | 4% | 1 | Cognito Therapeutics |
| 8 | Point72 Ventures | Venture capital firm | New York, United States | 1 | 4% | ||
| 9 | Goldman Sachs Asset Management | Investment bank | New York, United States | 1 | 4% | ||
| 10 | Sixth Street | Private equity firm | San Francisco, United States | 1 | 4% | ||
| 11 | Maverick Ventures | Venture capital firm | San Francisco, United States | 1 | 4% | ||
| 12 | AllianceBernstein | Hedge fund | New York, United States | 1 | 4% | ||
| 13 | SymphonyAI | Venture capital firm | Palo Alto, United States | 1 | 4% | ||
| 14 | Declaration Partners | Private equity firm | New York, United States | 1 | 4% |
Table 3. Biotech startups that raised Series C in Cambridge, Massachusetts: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 22 | 96% | $3.8B |
| Artificial intelligence | 2 | 9% | $604.5M |
| Software | 2 | 9% | $604.5M |
| Hardware | 1 | 4% | $321.8M |
Table 4. Biotech startups that raised Series C in Cambridge, Massachusetts by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series C | 23 | 100% | $73.9M |
Table 5. Biotech startups that raised Series C in Cambridge, Massachusetts by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 1 | 25% | $15.0M |
| June 2026 | 1 | 25% | $85.0M |
| March 2026 | 2 | 50% | $155.0M |
Table 6. Biotech startups that raised Series C in Cambridge, Massachusetts: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 4 | 17% | $255.0M |
| 2025 | 3 | 13% | $373.4M |
| 2024 | 1 | 4% | $95.0M |
| 2023 | 1 | 4% | $86.5M |
| 2022 | 2 | 9% | $273.0M |
| 2021 | 2 | 9% | $115.0M |
Table 7. Biotech startups that raised Series C in Cambridge, Massachusetts by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 2 | 9% |
| 2015 to 2019 | 10 | 43% |
| 2010 to 2014 | 6 | 26% |
| Before 2010 | 5 | 22% |
Table 8. Biotech startups that raised Series C in Cambridge, Massachusetts by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 2 | 9% |
| 11 to 50 | 9 | 39% |
| 51 to 100 | 9 | 39% |
| 101 to 250 | 2 | 9% |
| 1,001 to 5,000 | 1 | 4% |
Table 9. Biotech startups that raised Series C in Cambridge, Massachusetts by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is Series C and its headquarters is in Cambridge, Massachusetts. On 16 November 2026 that is 23 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 3 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 23 rows: 0 have no round amount, 0 no city and 1 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Cambridge, Massachusetts whose last round is Series C are on the list?
- 23, in the file dated 16 November 2026. 4 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 23 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.